Release Summary

Akaal Pharma Announces Positive Results from Phase 1 Clinical Study of Novel Topical AKP-11 for the Treatment of Psoriasis. Topical AKP-11 Meets Safety and Efficacy Endpoints.

Akaal Pharma Pty Ltd.